Claude AI Agents Discover Novel CRISPR-Like Enzyme System ART
Anthropic's AI model Claude has discovered a novel enzyme system, named Array-Associated Reverse Transcriptases (ART), in bacteriophage genomes, which exhibits CRISPR-like properties. The discovery was made by approximately 950 AI agents over 21 hours, analyzing 1.9 billion protein clusters. The ART system comprises a reverse transcriptase, a partner gene, and repeated DNA segments. This marks Anthropic's first major finding from its new biotech lab, which operates a molecular biology facility in the Bay Area (BSL-1 and BSL-2). CEO Dario Amodei envisions AI curing severe diseases within five to ten years. However, experts have mixed reactions, with some praising the finding as exciting and others cautioning it may not rival CRISPR. The function of ART remains unclear, and Anthropic is seeking collaborations with scientists to further explore its potential.
- •Anthropic's Claude AI discovered a novel CRISPR-like enzyme system called Array-Associated Reverse Transcriptases (ART).
- •The discovery used approximately 950 AI agents in 21 hours, analyzing 1.9 billion protein clusters.
- •ART consists of a reverse transcriptase enzyme, a partner gene, and repeated DNA segments.
